November 2020

December 23, 2020

In a live 2020 Directions in Oncology Pharmacy® conference session, the presenter provided an update on the management of cervical and endometrial cancers.

December 22, 2020

In a live 2020 Directions in Oncology Pharmacy® conference session, an update on research in the past decade that has led to improvements in the diagnosis, risk stratification, prevention, and treatment of acute graft-versus-host disease was provided.

December 21, 2020

Three monoclonal antibodies, 1 antibody-drug conjugate, and 1 nuclear export inhibitor have been approved by the FDA for relapsed/refractory (R/R) multiple myeloma in the past 4 years.

December 18, 2020

The COVID-19 pandemic has accelerated both acceptance and payment of novel care delivery models including telehealth.

December 17, 2020

A live 2020 Directions in Oncology Pharmacy® conference session emphasized pharmacist involvement in optimizing therapy with BTK inhibitors.

December 16, 2020

Advances in biotechnology have improved the production and recombination of antibodies, leading to improvements in monoclonal antibody therapies.

December 16, 2020

Counseling patients on possible adverse effects that impact skin health can help patients prepare for serious or cosmetic impacts.

December 15, 2020

The specialty drug pipeline is coming off a strong year, and the oncology pipeline has a wealth of potential oncolytics.

December 04, 2020

Targeted therapies often have better toxicity profiles, allowing patients to remain adherent and stay on medications longer.

December 03, 2020

Patients with relapsed/refractory leukemia and lymphomas generally have a grim prognosis, which has paved the way for immunotherapy treatments.

November 30, 2020

How has COVID-19 impacted our professional lives in providing care to patients with cancer, who are at even greater risk of contracting the virus and more likely to have higher morbidity and mortality should they be infected?

November 25, 2020

Pharmacists can play an integral role in educating patients with breast cancer to improve health outcomes.

November 24, 2020

A recent poll showed that more than 1 in 8 Americans engaged in a video consult with a health care professional in recent months.

November 24, 2020

Although ICIs have demonstrated excellent efficacy, they also have been associated with unique irAEs.

November 22, 2020

This activity is supported by educational grants from Dova Pharmaceuticals, INC. and Cure Media Group.

November 20, 2020

This month, Directions in Oncology Pharmacy® highlights a variety of ways that cancer care treatments are evolving, along with how practices are evolving, including best practices for the safety of health care workers such as oncology pharmacists.

November 19, 2020

By supplying proper PPE and infrastructure, health systems can keep workers safe and provide excellent patient care.

November 18, 2020

The series concludes looking at the proposition that patients with rare and devastating disorders require and deserve a higher acuity of care and service that only an accredited rare pharmacy can deliver.

November 16, 2020

Prescriptions for evidence-based cancer drugs increased under a pay-for-performance program without significantly impacting cost of care.